DK1151297T3 - Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar - Google Patents

Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar

Info

Publication number
DK1151297T3
DK1151297T3 DK00905755.5T DK00905755T DK1151297T3 DK 1151297 T3 DK1151297 T3 DK 1151297T3 DK 00905755 T DK00905755 T DK 00905755T DK 1151297 T3 DK1151297 T3 DK 1151297T3
Authority
DK
Denmark
Prior art keywords
members
binding
reactions
specific binding
pairs
Prior art date
Application number
DK00905755.5T
Other languages
English (en)
Inventor
Galla Chandra Rao
Leon W M M Terstappen
Paul A Liberti
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Application granted granted Critical
Publication of DK1151297T3 publication Critical patent/DK1151297T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Reinforced Plastic Materials (AREA)
  • Die Bonding (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK00905755.5T 1999-01-29 2000-01-27 Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar DK1151297T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/240,939 US6551843B1 (en) 1999-01-29 1999-01-29 Methods for enhancing binding interactions between members of specific binding pairs
PCT/US2000/002034 WO2000045169A1 (en) 1999-01-29 2000-01-27 Methods for enhancing binding interactions between members of specific binding pairs

Publications (1)

Publication Number Publication Date
DK1151297T3 true DK1151297T3 (da) 2010-03-01

Family

ID=22908555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905755.5T DK1151297T3 (da) 1999-01-29 2000-01-27 Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar

Country Status (11)

Country Link
US (1) US6551843B1 (da)
EP (1) EP1151297B1 (da)
JP (2) JP2002535677A (da)
AT (1) ATE449333T1 (da)
AU (1) AU2738900A (da)
CA (1) CA2359664A1 (da)
DE (1) DE60043335D1 (da)
DK (1) DK1151297T3 (da)
ES (1) ES2335080T3 (da)
PT (1) PT1151297E (da)
WO (1) WO2000045169A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
JP4663957B2 (ja) * 2000-07-14 2011-04-06 ベリデックス・リミテッド・ライアビリティ・カンパニー 磁性ナノ粒子の制御された凝集による増大した分離効率
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
US8980568B2 (en) * 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US7764821B2 (en) 2002-02-14 2010-07-27 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
CA2474509C (en) 2002-02-14 2012-01-31 Immunivest Corporation Methods and algorithms for cell enumeration in a low-cost cytometer
JP4593557B2 (ja) 2003-02-27 2010-12-08 ベリデックス・リミテッド・ライアビリティ・カンパニー 循環腫瘍細胞（ｃｔｃ）：転移癌患者における増悪までの時間、生存および療法に対する応答の早期評価
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
JP5537771B2 (ja) 2004-08-17 2014-07-02 ベリデックス・リミテッド・ライアビリティ・カンパニー 循環する希少細胞の分析用の画像診断機器
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
CN101166976B (zh) * 2005-01-13 2013-06-12 诺华疫苗和诊断公司 利用朊病毒特异性肽试剂的elisa试验
US7777885B2 (en) * 2005-08-17 2010-08-17 Veridex, Llc Diagnostic imaging device for the analysis of circulating rare cells
AU2006287299B2 (en) 2005-09-09 2012-08-23 Novartis Ag Prion-specific peptoid reagents
US8337755B2 (en) * 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
CN101583722A (zh) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
US7828968B2 (en) 2007-08-30 2010-11-09 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090061456A1 (en) * 2007-08-30 2009-03-05 Allard William J Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
US8110101B2 (en) * 2007-08-30 2012-02-07 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090117532A1 (en) * 2007-11-01 2009-05-07 Doyle Gerald V Pre-clinical method for monitoring serial changes in circulating breast cancer cells in mice
KR101604649B1 (ko) * 2007-11-27 2016-03-18 베리덱스, 엘엘씨 혈액 내 순환 흑색종 세포의 자동화된 계산 및 특징화
EP2229441B1 (en) 2007-12-12 2014-10-01 The Board of Trustees of The Leland Stanford Junior University Method and apparatus for magnetic separation of cells
US20090191535A1 (en) * 2007-12-22 2009-07-30 Mark Carle Connelly Method of assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
KR101384142B1 (ko) * 2007-12-28 2014-04-14 삼성디스플레이 주식회사 표시기판, 이의 제조방법 및 이를 갖는 표시장치
US9078932B2 (en) * 2008-02-04 2015-07-14 Emmetrope, Inc. Magnetic cells for localizing delivery and tissue repair
AU2009243060A1 (en) * 2008-04-30 2009-11-05 Novartis Ag. Assay for pathogenic conformers
WO2010044005A2 (en) * 2008-10-16 2010-04-22 Koninklijke Philips Electronics N.V. Method and device for determining the amount of magnetically labeled target components
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US20120077246A1 (en) 2009-04-24 2012-03-29 The Board Of Trustees Of The University Of Illinoi Methods and Devices for Capturing Circulating Tumor Cells
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
EP2496947A1 (en) 2009-11-04 2012-09-12 Novartis AG Positively charged species as binding reagents in the separation of protein aggregates from monomers
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
KR101212029B1 (ko) * 2011-12-20 2012-12-13 한국기초과학지원연구원 화합물 결합단백질 검출 방법
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US10900969B2 (en) 2014-03-07 2021-01-26 University Of Illinois Chicago Biomimetic microfluid device for capturing circulating tumor cells
EP3998335A3 (en) 2015-05-08 2022-07-27 Biomagnetic Solutions LLC Apparatus and method for immunomagnetic cell separation
EP3301445B1 (en) * 2016-09-30 2020-03-18 ARKRAY, Inc. Method for magnetically labeling particles
JP6754345B2 (ja) * 2016-09-30 2020-09-09 アークレイ株式会社 粒子の磁気標識方法及び標識装置
US11413378B2 (en) 2018-05-08 2022-08-16 Biomagnetic Solutions Llc Rigid chamber for cell separation from a flexible disposable bag
EP3693739A1 (de) * 2019-02-06 2020-08-12 Stefan Schreier Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970518A (en) 1975-07-01 1976-07-20 General Electric Company Magnetic separation of biological particles
US4018886A (en) 1975-07-01 1977-04-19 General Electric Company Diagnostic method and device employing protein-coated magnetic particles
US4267234A (en) 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4375407A (en) 1981-06-22 1983-03-01 The Franklin Institute High gradient magnetic separation device
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US4847193A (en) * 1987-06-18 1989-07-11 Gene-Trak Systems Signal amplification in an assay employing a piezoelectric oscillator
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
WO1996007101A1 (en) * 1994-08-31 1996-03-07 First Medical, Inc. Quantitative assays employing magnetizable particles for rate enhancement
JP3962789B2 (ja) 1995-02-21 2007-08-22 ダブリュー． シディキー，イクバール 磁性粒子を利用した混合／分離装置及びその方法
JPH08313539A (ja) * 1995-05-16 1996-11-29 Nittec Co Ltd 容器およびこの容器を用いた液体撹拌・洗浄・磁性体微粒子捕集方法並びに該容器を用いた免疫化学検査装置
US5985153A (en) * 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
EP1362918B8 (en) * 1998-07-01 2009-08-05 Takara Bio Inc. Gene transfer methods with retroviruses

Also Published As

Publication number Publication date
ATE449333T1 (de) 2009-12-15
WO2000045169A1 (en) 2000-08-03
US6551843B1 (en) 2003-04-22
JP2002535677A (ja) 2002-10-22
CA2359664A1 (en) 2000-08-03
DE60043335D1 (de) 2009-12-31
WO2000045169A9 (en) 2001-07-26
JP5442544B2 (ja) 2014-03-12
EP1151297A1 (en) 2001-11-07
JP2010261963A (ja) 2010-11-18
EP1151297A4 (en) 2003-04-09
EP1151297B1 (en) 2009-11-18
PT1151297E (pt) 2010-01-20
ES2335080T3 (es) 2010-03-22
AU2738900A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
DK1151297T3 (da) Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar
ATE431684T1 (de) Zellulares funknetz mit wiedergebrauch von frequenzen
NL1008997A1 (nl) Werkwijze voor het bereiden van alkyleenglycolen.
ATE368104T1 (de) Verbesserte nukleinsäure-modifizierende enzyme
DE69940301D1 (de) Zeitaufteilung von Kommunikationsressourcen in zellularen Kommunikationssystemen
MX167359B (es) Sistema de comunicaciones de radiotelefono celular
ES2190132T3 (es) Procedimiento de preparacion enzimatica de homogentisato.
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
DK1214344T3 (da) Dipeptidylpeptidaser
BR9803807B1 (pt) processo para preparação de uma enzima heteróloga através do cultivo de uma célula eucariótica transformada.
TW365715B (en) Sending-receiving-converting arrangement
BR9800515A (pt) Processo para a preparação de um sistema catalisador de metaloceno
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
BR0200574B8 (pt) Processo para hidroprocessar alimentação de hidrocarboneto.
DE69923676D1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
DE60113135D1 (de) Blindbefestiger
TR199901283A3 (tr) Bagimsiz çalisan ve hareketli bir radyatörün üretilmesi süreci.
TR200000624T2 (tr) Bir enzimin etkinliğinin arttırılması ile ilgili bir yöntem.
DK1242816T3 (da) Kromatografimateriale og fremgangsmåder ved anvendelse af dette
AU2003233579A8 (en) Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
ATE542142T1 (de) Referenzlösung
WO2002017900A3 (en) Modulators of us28 (chemokines) for treating cytomegalovirus infections
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
FR2793703B1 (fr) Procede de fabrication de compositions utilisables comme agents de surface emulsifiants et dispersants, les compositions obtenues et leurs utilisations
DE59903589D1 (de) Prozesssteuerung